Clinical trials
Multiple Sclerosis, Relapsing-Remitting trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Terminated | 12 |
| Active, not recruiting | 4 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 18 |
| Genzyme, a Sanofi Company | 6 |
| Novartis Pharmaceuticals | 5 |
| Bayer | 4 |
| Hoffmann-La Roche | 4 |
| McGill University | 3 |
| Genentech, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Novartis | 2 |
| Sanofi | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 64 |
| Multiple Sclerosis | 30 |
| Demyelinating Diseases | 4 |
| Recurrence | 4 |
| Autoimmune Diseases | 2 |
| Autoimmune Diseases of the Nervous System | 1 |
| Demyelinating Autoimmune Diseases, CNS | 1 |
| Diffuse Cerebral Sclerosis of Schilder | 1 |
| Disease Progression | 1 |
| Immune System Diseases | 1 |
Trials
Showing 51 to 64 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.